495.00 +0.36 (0.07%)
After hours: 7:55PM EDT
|Bid||493.00 x 800|
|Ask||494.00 x 1000|
|Day's range||485.81 - 499.28|
|52-week range||441.00 - 664.64|
|Beta (5Y monthly)||0.19|
|PE ratio (TTM)||16.21|
|Earnings date||06 May 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||645.59|
The biotech sector was in focus last week with regulatory updates from Gilead (GILD) and COVID-19 study updates from Regeneron (REGN), among others.
Dr. Taison Bell, Assistant Professor of Medicine in the divisions of Infectious Diseases and Pulmonary & Critical Care Medicine at the University of Virginia, joins Yahoo Finance’s Kristin Myers and Alexis Christoforous to discuss the latest on the coronavirus.
Craig Singleton, Adjunct Fellow at Foundation for the Defense of Democracies, joins Yahoo Finance’s Anjalee Khemlani and Kristin Myers to discuss reforming the WHO in the wake of the coronavirus pandemic.